NATIONAL HARBOR, MD—Patients with functional mitral regurgitation (MR) treated with the Carillon device have sustained benefit and a 56.2% survival rate out to 5 years, according to results of a ...
Please provide your email address to receive an email when new articles are posted on . Patients with congestive HF and grade 2 to 4 functional mitral regurgitation despite medical therapy who ...
KIRKLAND, Wash.-- Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure (HF), today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results